Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BNIT Co., Ltd. is a South Korean biotechnology company specializing in the development and manufacturing of advanced molecular diagnostic solutions. The company leverages its proprietary Bio-Nano-Information Technology platform to create high-sensitivity PCR kits and bio-chip based diagnostic tools for infectious diseases. BNIT gained significant prominence for its rapid development of COVID-19 diagnostic kits, which have been utilized globally. Beyond respiratory viruses, the company is expanding its portfolio into oncology diagnostics and personalized medicine applications. BNIT focuses on integrating nanotechnology with molecular biology to provide faster and more accurate point-of-care testing solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BNIT.